6:04 PM
 | 
Oct 22, 2008
 |  BC Extra  |  Top Story

Amgen beats Street, raises guidance

Amgen (NASDAQ:AMGN) reported 3Q08 adjusted diluted EPS of $1.23, beating by $0.15 the Street's estimate of $1.08 and up 14% from $1.08 in 3Q07. Third quarter revenues were up 7% to $3.9 billion from...

Read the full 155 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >